US EditionWhy Weight Loss Drugs Could Help People Cut Back on Their Drinking
Researchers found GLP-1 agonist weight loss drugs delay alcohol absorption, potentially reducing drinking appeal by changing the timing of alcohol’s effects on the brain.
- Researchers at Virginia Tech found GLP-1 agonist weight-loss drugs in the Ozempic family slow alcohol absorption, altering how quickly alcohol affects the brain.
- With few established treatments, researchers say altering the immediate sensation of drinking can change a drug's addictive potential for alcohol use disorder.
- The study found consistent effects across different GLP-1 drugs, reporting that weight-loss medications delay alcohol entering the bloodstream, so intoxication takes longer for study participants.
- Researchers suggest the drugs might help people reduce drinking because delaying early drinking sensations appears linked to reduced consumption, the authors of the Virginia Tech study say.
- Alex DiFeliceantonio said delayed rewards tend to be less motivating, but researchers warn relapse remains common among people in recovery or with relapse risk.
40 Articles
40 Articles
Why weight loss drugs could help people cut back on their drinking
Weight loss drugs have profound health impacts, and researchers at Virginia Tech said they’ve discovered another one. Excessive alcohol consumption is associated with serious health risks, including liver disease and increased cancer rates. However, a new study from the university reveals that GLP-1 agonist drugs — commonly used for weight loss — affect alcohol absorption in the same way they influence food digestion. These medications slow the …
Drinking without getting drunk might be possible with the help of one of the members of the 'Ozempic' family. It may sound promising, even though there are still rehearsals that...
Weight loss drugs can delay alcohol’s effects, help people fighting addiction - News Today
Popular drugs for diabetes management and weight loss, such as Ozempic and Wegovy, could also be effective in reducing alcohol use, according to a study. The study, led by researchers at Virginia Tech, US, showed that GLP-1 agonists slow the speed at which alcohol enters the bloodstream, also slowing down the effects on the brain. “People who drink know there’s a difference between nursing a glass of wine and downing a shot of whiskey,” said Al…
Coverage Details
Bias Distribution
- 37% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
